September 2017

Update from the Dean - September 2017

Strategic plan progress report. Research: Driving the development of innovative and precise drugs, medical devices, and diagnostic tests. Flu treatments; Tackling antimalarial resistance; Attacking hard targets; Plotting cell maps; Safer opioid pain killer; Cellular construction; New products through bioengineering; Regulatory science leadership; Tobacco burden in vulnerable populations; Economics of disease; Precision medicine.

Guo applies curiosity and collaboration to research

“There are lots of important problems. Only attack those for which you can divine simple experiments with clear answers.”
—Julius Axelrod

This quotation is a guiding principle for Su Guo, PhD, professor in the Department of Bioengineering and Therapeutic Sciences (BTS). Her research employs the unique strengths of a simple vertebrate, the zebrafish (Danio rerio), to address a wide variety of topics related to neuroscience.

Giacomini to receive North American Scientific Achievement Award

Kathy Giacomini, PhD, a leader in the field of pharmacogenomics, has been named the 2017 recipient of the North American Scientific Achievement Award, presented by the International Society for the Study of Xenobiotics (ISSX). ISSX is an international association of scientists that promotes the understanding of the interactions of medicines and chemicals with living systems.

“What makes it so special to me is that I was nominated by friends and colleagues,” Giacomini says.